Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Lilly: Zepbound, Mounjaro supply to remain tight through 2024
While Lilly's incretin supply should increase during the second half of the year, demand is still expected to outpace supply at least through 2024.
Zoey Becker
Apr 30, 2024 12:03pm
J&J, BMS set to appeal losses in IRA drug pricing lawsuits
Apr 30, 2024 11:48am
Sponsored
ADVI Experts Discuss the Future of the Inflation Reduction Act
Apr 29, 2024 8:00am
Lilly’s growth drivers, Verzenio and Jardiance, suffer setbacks
Apr 30, 2024 10:48am
Sponsored
Collaborative partnerships key to clearing the path for new biopharma products
Apr 29, 2024 8:00am
CPI unveils next leg of its digital manufacturing journey
Apr 30, 2024 10:23am